Getinge appoints Elin Frostehav as President Acute Care Therapies and Eric Honroth as President Life Science
Getinge has appointed Elin Frostehav as President of Acute Care Therapies and Eric Honroth as President of Life Science, effective April 1, 2022. Frostehav, previously Vice President of Critical Care, has been with Getinge since 2019, bringing extensive experience in product development and digitalization. Honroth, who has been with Getinge since 2018, previously led the North America Region and has over 20 years of experience in medical devices. These appointments follow the retirement of Harald Castler and the reassignment of Jens Viebke.
- Elin Frostehav brings valuable experience from prior roles in product development and critical care.
- Eric Honroth's leadership in North America adds significant market insight.
- The retirement of Harald Castler may create a gap in leadership continuity.
GETINGE, Sweden, Jan. 17, 2022 /PRNewswire/ -- Getinge appoints new Presidents for two business areas and members of the Executive team. Elin Frostehav is appointed President Acute Care Therapies and Eric Honroth President Life Science starting April 1, 2022.
Elin Frostehav has been appointed President Acute Care Therapies and member of the Getinge Executive team. Elin currently serves as Vice President Critical Care, a product area within Acute Care Therapies in Getinge. Elin joined Getinge in 2019 and has previously held leading global positions within Semcon, an international technology company, in the areas of product development and digitalization. Prior to Semcon Elin held various positions at FlexLink, a global factory automation company. Elin succeeds Jens Viebke who will take on a new role in Getinge as Executive Vice President Research & Business Development, focusing on Getinge's Research Programs and M&A activities. In this role, Jens Viebke will continue to report to Mattias Perjos, President & CEO. He will not be a member of the Executive Team.
Eric Honroth has been appointed President Life Science and member of the Getinge Executive team. Eric is currently President North America Region in Getinge and has been with the company since 2018. He has more than 20 years of extensive experience in global leadership roles in the medical devices industry such as Becton Dickinson, CareFusion and Abbott Vascular. Eric succeeds Harald Castler who after a long and successful career in Getinge has decided to retire.
All changes are effective as of April 1, 2022.
Media contact
Anna Appelqvist, VP Corporate Communications
Phone: +46 734 244 527
Email: anna.appelqvist@getinge.com
About Getinge
With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions aiming to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs over 10,000 people worldwide and the products are sold in more than 135 countries.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
Getinge appoints Elin Frostehav as President Acute Care Therapies and Eric Honroth as President Life Science | |
Elin Frostehav | |
https://news.cision.com/getinge/i/eric-honroth--getinge,c3000644 | Eric Honroth, Getinge |
View original content:https://www.prnewswire.com/news-releases/getinge-appoints-elin-frostehav-as-president-acute-care-therapies-and-eric-honroth-as-president-life-science-301462006.html
SOURCE Getinge
FAQ
Who is Elin Frostehav, and what is her new role at Getinge?
What experience does Eric Honroth bring to his new position at Getinge?
What changes are occurring in Getinge's Executive team?
What role will Jens Viebke assume following his change in position?
